Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer(†)

BACKGROUND: We previously reported the safety of concurrent cetuximab, an antibody against epidermal growth factor receptor (EGFR), pemetrexed, and radiation therapy (RT) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). In this non-comparative phase II randomiz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Oncol
Main Authors: Argiris, A., Bauman, J. E., Ohr, J., Gooding, W. E., Heron, D. E., Duvvuri, U., Kubicek, G. J., Posluszny, D. M., Vassilakopoulou, M., Kim, S., Grandis, J. R., Johnson, J. T., Gibson, M. K., Clump, D. A., Flaherty, J. T., Chiosea, S. I., Branstetter, B., Ferris, R. L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279075/
https://ncbi.nlm.nih.gov/pubmed/27177865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados